Biovation's Acquisition

Biovation was acquired by Merck KGaA - German Consumer Health Business on October 27, 2000.

Biovation focuses on proprietary technologies that eliminate immunogenicity in antibodies and other proteins in order to develop biotherapeutic drugs with a superior safety profile. Biovation's techno…

Articles about Biovation's Acquisition: